Imagion Biosystems Limited Appendix 4E for the year ended 31 December 2017 has been lodged with ASX under Listing Rule 4.3A.
Download FY 2017 Appendix 4E and Financial Report
Quarterly Activity Report – Quarter ending 31 December 2023
Highlights: Announced positive results from IBI10103 Phase I Study demonstrating safety and clinical feasibility of molecular MRI with MagSense® HER2 Imaging Agent Presented new animal